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Abstract
Vitamin D is an important regulator of immune function and largely acts to dampen chronic
inflammatory events in a variety of tissues. There is also accumulating evidence that vitamin
D acts to enhance initial inflammation, beneficial during both infection and wound healing,
and then promotes resolution and prevention of chronic, damaging inflammation. The cur-
rent study examines the effect of topical vitamin D in a mouse of model of corneal epithelial
wound healing, where acute inflammation is necessary for efficient wound closure. At 12
and 18 hours post-wounding, vitamin D treatment significantly delayed wound closure by
~17% and increased infiltration of neutrophils into the central cornea. Basal epithelial cell
division, corneal nerve density, and levels of VEGF, TGFβ, IL-1β, and TNFα were
unchanged. However, vitamin D increased the production of the anti-microbial peptide
CRAMP 12 hours after wounding. These data suggest a possible role for vitamin D in modu-
lating corneal wound healing and have important implications for therapeutic use of vitamin
D at the ocular surface.
Introduction
Vitamin D is a pleiotropic molecule that has widespread effects not only on calcium homeosta-
sis, but also cellular differentiation, proliferation, and immune responsiveness [1–4]. 1,25 dihy-
droxyvitamin D (1,25D3), the active form of vitamin D, has been widely studied for its
immunomodulatory properties and is known to suppress inflammation in a variety of tissues,
largely through its influence on antigen presenting cell differentiation, lymphocyte prolifera-
tion, innate immune receptor signaling, and cytokine and chemokine expression [3,5,6]. In
addition to its beneficial effects during inflammatory events, vitamin D also induces the expres-
sion of antimicrobial peptides [7–9], potentially providing enhanced protection during infec-
tion and wound healing.
The cornea is the transparent tissue at the front of the eye that serves both to refract light
back onto the retina and to protect the underlying tissues from damage. Following a corneal
epithelial abrasion, there is a well-characterized local inflammatory response that is necessary
for efficient wound healing and re-epithelialization to help rapidly restore optimal vision [10–
13]. This process of corneal wound healing involves interactions between epithelial cells, stro-
mal keratocytes, leukocytes, platelets, and nerves which are mediated by growth factors,
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cytokines, and adhesion molecules [14]. After epithelial debridement, there is a coordinated
response between all of these components to ensure efficient wound closure. Basal epithelial
cells migrate into the wounded area and undergo division to re-epithelialize and then re-stratify
the injured area. Inflammatory signals from the epithelium induce keratocyte death and injury
triggers the infiltration of immune cells into the cornea from the limbal vessels [14–16]. This
infiltration is necessary for proper wound healing, as defects in neutrophil trafficking result in
delayed re-epithelialization [10–12,17]. In addition to a loss of neutrophil infiltration, too
much accumulation also results in delayed wound closure [13,18], demonstrating the delicate
balance of inflammatory events needed during corneal healing. Migration of other immune
cells, including dendritic cells, Natural Killer (NK) cells, and γδ T lymphocytes also infiltrate
into the cornea and influence recovery [12,13,19].
Corneal nerves also contribute to the wound healing process [20]. The cornea is one of the
most densely innervated tissues in the body, serving both to protect the cornea from damage
and to provide trophic factors necessary for corneal health and normal maintenance [21–24].
Corneal nerves stem from the ophthalmic lobe of the trigeminal ganglion and thick stromal
nerves traverse the anterior limiting lamina to enter the epithelium. These epithelial nerves
form a network, the subbasal nerve plexus, of thin, unmyelinated nerve fibers that run parallel
to one another [25]. The density of the epithelial nerves increases towards the center of the cor-
nea and they have been shown to respond to chemical, mechanical, and thermal stimulation
[26]. Upon epithelial debridement, the thin subbasal nerves are destroyed and regeneration
begins toward the wound center. Platelets, neutrophils, and γδ T cells have been shown to aid
in this process with the release of specific growth factors and cytokines [27].
Both in animal models and in human studies, vitamin D supplementation has been found
to produce therapeutic effects on inflammatory conditions. Therefore, in the current study, a
mouse model of corneal epithelial debridement was employed to examine the effect of topical
vitamin D treatment on wound closure, neutrophil infiltration, and early nerve regeneration
following wounding. The ultimate goal of this work is to provide an increased understanding
of vitamin D at the ocular surface and examine its therapeutic potential in this tissue.
Materials and Methods
Mouse Model of Corneal Wound Healing
A total of 102 female C57BL/6 mice (8–12 weeks old, Jackson Laboratories, Bar Harbour, ME)
were used in these studies. As there is a difference in the rate of wound closure based on sex,
only female mice were used in these studies [28]. Prior to wounding, mice were weighed and
anesthetized with an intraperitoneal injection of ketamine/xylazine (75mg/7.5mg/Kg body
weight) (Vedco, Inc., St. Joseph, MO). Circular epithelial wounds (~2mm in diameter) were
made in the center of the right eye with an Algerbrush II (Alger Equipment Co., Lago Vista,
TX) under a dissecting microscope. This method has been used previously to debride the cor-
neal epithelium without disruption of the epithelial basement membrane [10,11,17]. All
wounding experiments were started at the same time of day to minimize diurnal variations in
inflammatory events.
Immediately following wounding and imaging, topical vitamin D (1,25D3; Sigma-Aldrich,
St. Louis, MO) (10−7–10-9M) or vehicle (0.02% ethanol/PBS) was applied drop wise (5μl) to
wounded corneas. Drops were repeated 5 minutes after the initial application and every 6
hours over the course of the experiments. Eyes were manually held open to avoid blinking for
30 seconds following drop administration. All mice were euthanized by carbon dioxide asphyx-
iation followed by cervical dislocation at the end of the experiments. This protocol was
approved by the Institutional Animal Care and Use Committee at the University of Houston,
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and adhered to the standards of the Association for Research in Vision and Ophthalmology
Statement for the use of animals in ophthalmic and visual research.
Corneal Wound Imaging
To determine wound size and monitor re-epithelialization, wounded corneas were imaged at
the time of wounding and every 6 hours afterwards for 24 hours. Isoflurane anesthesia was
administered to each animal before imaging, except at the time of initial imaging. Briefly, mice
were placed in an induction box and isoflurane was administered via vaporizer (EZ‐Anesthesia,
model EZ‐SA800) at a dosage of 1–4% inhalant and O2 flow rate of 0.5–1 liter/minute until
there was lack of a reflex to a rear toe pinch. For imaging, 1μl of 1% sodium fluorescein
(Sigma-Aldrich) was pipetted onto the central cornea and images were captured with an Olym-
pus stereomicroscope (Model SZX16). For determining percentage of wound closure, wound
areas were demarcated and measured using Image J software. The size of the epithelial defect
was expressed as a percentage of the original wound area. Results were analyzed with a two-
way repeated measure ANOVA and Bonferroni’s test for multiple comparisons with signifi-
cance set at p<0.05.
Corneal Whole Mount Imaging
At 18 hours post-wounding, a time demonstrated to correlate to peak neutrophil infiltration
[10], mice were euthanized for corneal whole mount processing. Whole eyes were removed
and placed in 2% paraformaldehyde for 15 minutes. Corneas were then dissected and fixed for
an additional 45 minutes. Following blocking and permeabilization (2% BSA/0.01% Triton-
X100 in PBS), corneas were incubated overnight at 4°C with 10μg/ml fluorophore-conjugated
antibodies: FITC-conjugated anti-Ly6G (to detect neutrophils) (clone 1A8, BD Pharmingen,
San Diego, CA), NorthernLights™NL557-conjugated anti-β-III tubulin (to detect nerves)
(R&D Systems, Minneapolis, MN), and DAPI (4',6-diamidino-2-phenylindole, Sigma-Aldrich)
to visualize nuclei. Corneas were radially cut to flatten, mounted onto slides with Airvol (Cela-
nese, Dallas, TX, courtesy of Dr. A. Burns) and imaged on a DeltaVision Core microscope
(Applied Precision, Issaquah, WA).
Full thickness images were captured from seven fields of view across the diameter of the cor-
nea, centered at evenly spaced intervals, from limbus to limbus on the opposite side (Fig 1). x-
and y- image coordinates were used to calculate the distance between points. Each image was
deconvolved five iterations to improve resolution and reduce blur using SoftWorx software
(Applied Precision) [29]. For neutrophil infiltration, nuclei were counted within a square mor-
phometric frame (150 μm in length) (S1 Fig). Both DAPI and FITC-Ly6G staining were used
to identify neutrophils, with distinctive “donut-shaped” nuclei (polymorphonuclear), which
were located predominantly in the anterior stroma, as previously reported [13] and only those
cells which fell within the frame or on the accepted line were counted. A similar method was
used to count dividing basal epithelial cells, which were identified by DAPI nuclear staining,
enabling visualization of condensed chromosomes that occur during mitosis. For relative
nerve-density determination, a 10x10 grid was overlaid on each image and the presence or
absence of stained subbasal epithelial nerves in each square of the grid was recorded to obtain a
percentage of squares containing nerves stained with neuron-specific anti-β-III tubulin (S2
Fig).
Corneal RNA Collection and RT-PCR
Whole corneas were collected for RT-PCR analyses of gene expression 12 and 24 hours post-
wounding. Following euthanasia, eyes were removed and corneas harvested with the aid of a
Vitamin D and Corneal Wound Healing
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dissecting microscope. Eight to ten corneas (from 4–5 mice) were pooled from the same treat-
ment group for each sample. Samples were homogenized on ice and RNA was extracted with
an Ambion ToTALLY RNA Total RNA Isolation kit (Life Technologies, Grand Island, NY),
using two sequential phenol:chloroform extractions for purification. RNA concentration was
quantified with a NanoDrop 2000 spectrophotometer (Thermo Scientific, Wilmington, DE)
and reverse transcribed using an AffinityScript cDNA synthesis kit (Agilent Technologies,
Santa Clara, CA). Real-time PCR was performed using intron-spanning primers (Table 1) and
Brilliant II SYBR Green QPCR master mix (Agilent Technologies). All samples were normal-
ized to GAPDH and control samples served as the calibrator for relative quantity determina-
tion using the ΔΔCT method.
ELISA
Levels of CXCL1, CXCL2, TNFα, IL1β, and VEGF were determined 12 and 24 hours after
wounding. Whole corneas were harvested and protein isolated as previously described [30].
Eight corneas (from 4 mice) per group were pooled and homogenized in 1ml PBS with protease
Fig 1. Corneal whole mount imaging. (A) Example of a whole mount, 18 hours post-wound, stained with
Ly6G (green) to visualize infiltrating neutrophils and DAPI (blue). Radial cuts divide the cornea into four
petals, enabling the cornea to flatten under the coverslip. The wound area is visible in the central cornea
surrounded by the parawound region (yellow). The location of the original wound margin is demarcated (red).
Scale bar = 100μm (B) Each cornea was measured from the limbus across the center to the opposite limbal
region using x- and y- image coordinates and images were taken at even intervals, designated by points 1
through 4.
doi:10.1371/journal.pone.0152889.g001
Table 1. Primer sequences for real-time PCR.
Gene name Forward Primer Reverse Primer NCBI Reference Sequence
CXCL1 5’- TGCACCCAAACCGAAGTC-3’ 5’- GTCAGAAGCCAGCGTTCACC-3’ NM_008176.3
CXCL2 5’-TGTCAATGCCTGAAGACCCTGCC-3’ 5’-AACTTTTTGACCGCCCTTGAGAGTGG-3’ NM_009140.2
IL-1α 5’- CAGGGCAGAGAGGGAGTCAAC-3’ 5’- CAGGAACTTTGGCCATCTTGAT-3’ NM_010554
Il-1β 5’- GCAACTGTTCCTGAACTCAACT-3’ 5’- ATCTTTTGGGGTCCGTCAACT-3’ NM_008361
VEGFA 5’- GTCCTGTGTGCCGCTGATG-3’ 5’- GCTGGCTTTGGTGAGGTTTG-3’ NM_001025250
TGFβ1 5’-CTTCAATACGTCAGACATTCGGG-3 5’- GTAACGCCAGGAATTGTTGCTA-3’ NM_011577
TGFβ2 5’- CTTCGACGTGACAGACGCT-3’ 5’-TTCGCTTTTATTCGGGATGATG-3’ NM_009367
TNFα 5’- ACTGAACTTCGGGGTGATCG-3’ 5’- TGATCTGAGTGTGAGGGTCTGG-3’ NM_013693.3
PDGFα 5’- TGGCTCGAAGTCAGATCCACA-3’ 5’- TTCTCGGGCACATGGTTAATG-3’ NM_008808
doi:10.1371/journal.pone.0152889.t001
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inhibitors (cOmplete, mini tablets, Roche Diagnostics, Indianapolis, IN). Cells were then lysed
through three freeze-thaw cycles and centrifuged at 10,000g. Total protein concentrations were
determined in supernatants by BCA protein assay (Life Technologies) and target protein
expression quantified in duplicate using DuoSet ELISA kits (R&D Systems). Results were
expressed as amount of target protein per mg total protein from each sample.
Human Organ Culture Model
Human cornea organ culture wounding was performed as previously described [31]. Briefly,
cadaveric corneas, supplied by Saving Sight (St. Louis, MO), were received within five days of
donor death, stored in corneal preservation media (Life 4°C, Numedis, Inc., Isanti, MN), and
shipped overnight at 4°C. Upon receipt, corneas with epithelial defects were excluded and only
corneas with an intact epithelium were used in these experiments. Corneas were placed epithe-
lial side up in a culture dish supported by a 0.5% agar/M199 mold. In order to examine how
gene expression was affected by wounding, the epithelium was removed and allowed to regrow
for 48 hours. Briefly, corneas were gently marked with a 6mm trephine and the epithelium was
removed from the corneas by scraping (initial sample), allowed to regrow, and collected again
after 48 hours (regrown sample). RNA was isolated and analyzed by RT-PCR for expression of
CYP27B1, the hydroxylase that converts vitamin D to its active form, 1,25D3. For wound clo-
sure studies, 1,25D3 (10
-7M) (right eye, OD) or vehicle (0.02% ethanol/PBS) (left eye, OS) was
applied drop wise to wounded corneas every 6 hours for 24 hours and the wound area deter-
mined by fluorescein staining, as in the mouse wounding model (described above). Results
were analyzed with a two-way repeated measure ANOVA and Bonferroni’s test for multiple
comparisons with significance at p<0.05. Five corneas for each treatment, vehicle or 1,25D3,
were used in the analysis.
Results
Topical vitamin D slows corneal wound closure in the initial 18 hours
To determine the effect of vitamin D on wound closure, topical 1,25D3 (10
-7M, S3 Fig) was
administered every 6 hours to wounded corneas and re-epithelialization was evaluated over 24
hours. 1,25D3 treated mice had a significantly delayed rate of wound closure, indicated by a
greater percentage of wound remaining open, at both 12 and 18 hours compared to vehicle
treatment (p<0.05) (Fig 2). Following epithelial debridement, wounds from normal mice were
nearly completely re-epithelialized within 24 hours [10], as was seen with vehicle treatment,
having only 2.16% of the wound area remaining open. 1,25D3 treated wounds were not
completely closed at this time (12.01% open), however this difference did not reach statistical
significance. Vehicle treatment alone did not alter the rate of wound closure compared to
untreated control wounds.
Vitamin D treatment does not affect basal epithelial cell division
Re-epithelialization of a corneal wound involves both migration and division of basal epithelial
cells to cover the wound. Because vitamin D delayed wound closure, the amount of basal epi-
thelial cell division was quantitated to determine if this process was affected by treatment. At
18 hours after epithelial debridement, there was no significant change in dividing epithelial cell
numbers between vehicle and 1,25D3 treatment groups across the cornea (Fig 3). This suggests
that the delay seen in corneal wound healing with vitamin D was not due to reduced basal cell
division. However, the power of this experiment was only 0.60, indicating that a difference
might arise with an increased sample size.
Vitamin D and Corneal Wound Healing
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Fig 2. In vivowound closure is delayed with vitamin D treatment.Mice were wounded and treated with vehicle (0.02% ethanol/PBS) or 1,25D3 (10-7M)
every 6 hours or left untreated (control) for 24 hours. (A) Corneal wound areas were monitored by fluorescein staining every 6 hours. (B) Wound area
remaining open was determined as a percentage of original wound area. Data represent mean ± SEM and were analyzed with two-way repeated measures
ANOVA and Bonferroni’s correction for multiple comparisons. * = p<0.05 (comparison between vehicle and vitamin D treatments; n = 9 mice/group).
doi:10.1371/journal.pone.0152889.g002
Vitamin D and Corneal Wound Healing
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Neutrophil infiltration into the wound area is increased by vitamin D
treatment
Neutrophil extravasation and emigration into the cornea is an important part of the wound
healing process and neutrophil depletion causes a delay in wound healing [10]. Therefore, we
next examined neutrophil infiltration in wounded corneas at 18 hours post-wounding, the
time of peak neutrophil accumulation in corneas under control conditions [10]. Vitamin D
treatment increased the relative number of total neutrophils in the wounded corneas by 40%
compared to vehicle (674 vs. 401; p<0.01) (Fig 4A). Specifically, there were more neutrophils
in the parawound (p<0.01) and wound center (p<0.0001) regions with 1,25D3 treatment (Fig
4B).
Fig 3. Basal epithelial cell division across the wounded cornea at 18 hours after wounding. Nuclei of
basal epithelial cells were identified with DAPI staining. The graph represents the average number of mitotic
nuclei counted per field in vehicle or 1,25D3 treated corneas 18 hours after wounding. (n = 5 corneas/group).
doi:10.1371/journal.pone.0152889.g003
Fig 4. Vitamin D treatment increases neutrophil infiltration in wounded corneas. (A) Total neutrophil
counts across the cornea at 18 hours post-wound from fields 1 through 4. Data represent mean ± SEM and
were analyzed with Student’s two-tailed t-test, p<0.01 (n = 6). (B) Neutrophil counts per field in vehicle or
vitamin D-treated corneas at 18 hours after wounding. Statistical analysis was by two way ANOVAwith
Bonferroni’s test for multiple comparisons. p<**0.01, ****<0.0001 (n = 6).
doi:10.1371/journal.pone.0152889.g004
Vitamin D and Corneal Wound Healing
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Levels of CXCL1 are increased at 12 hours after wounding with vitamin
D treatment
Neutrophils migrate into the cornea from the limbal vessels in response to chemotactic signals
resulting from injury. As vitamin D treatment increased neutrophil migration into the
wounded area 18 hours after epithelial debridement we examined the expression of CXCL1
and CXCL2, molecules known to be expressed in the cornea and to enhance neutrophil chemo-
taxis [32,33], in wounded corneas. At 12 hours after wounding, prior to the 18 hour peak of
neutrophils in the cornea, there was a 38% increase in CXCL1 protein expression with vitamin
D treatment, above the increase seen with vehicle (Fig 5A top). However, there was no change
at this time point with CXCL2 (Fig 5B top). By 24 hours post-wounding, after the peak neutro-
phil infiltration, there was a decrease in CXCL1 expression with vitamin D, below the level of
vehicle treatment. In addition, while CXCL2 levels were increased at 24 hours with vehicle
treatment, compared to unwounded controls, there was no increase in CXCL2 expression in
the vitamin D treated corneas. Examining gene expression, there was no change in CXCL2 rel-
ative RNA quantity with treatment at either time point (Fig 5B bottom) but a decrease in
Fig 5. Chemokine CXCL1 and CXCL2 expression in wounded corneas.CXCL1 (A) and CXCL2 (B) expression was determined in corneal homogenates
following 12 and 24 hours of wounding. For protein analysis (top row), 8 corneas were isolated per time point per treatment group for each experiment, were
pooled, and total corneal protein was collected for ELISA analysis of chemokine expression. Graphs are representative data from one experiment (n = 2,
24hrs; n = 1, 12hrs) showing the mean and ± SD of duplicate technical repeats. For RNA analysis (bottom row), relative gene expression was determined by
RT-PCR analysis. 10 individual corneas were isolated per time point per treatment group for each experiment. Graphs are representative data from one
experiment (n = 3, 24hrs; n = 1, 12hrs) showing the mean ± SEM of triplicate technical repeats.
doi:10.1371/journal.pone.0152889.g005
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CXCL1 at 12 hours (Fig 5A bottom). Wounded corneas, regardless of treatment, had increases
in both CXCL1 and CXCL2 relative to unwounded corneas at both time points (bottom).
Vitamin D does not affect early nerve regeneration or VEGF expression
in the wounded corneas
Upon epithelial debridement, the thin subbasal nerves are destroyed in the wounded area.
These nerves regenerate during wound healing, however, they only reach 65% of their original
density by 28 days after wounding [24]. Vascular endothelial growth factor (VEGF) has been
shown to be important in promoting nerve regeneration following corneal epithelial debride-
ment and is upregulated after wounding [24,34]. In other tissues, vitamin D has been shown to
modulate VEGF levels, with differing responses dependent on cell type and tissue condition
[35–37]. Therefore, we next examined if there was a change in relative nerve densities and
VEGF expression between treatment groups early in the regeneration process.
There was no significant difference in subbasal nerve density with 1,25D3 treatment com-
pared to vehicle in any corneal region (Fig 6A). In addition, there was no change in either
VEGF mRNA or protein expression 12 and 24 hours after wounding with topical 1,25D3 treat-
ment. There was however, the expected increase in VEGF when compared to unwounded con-
trols (3-fold increase) (Fig 6B). These data suggest that vitamin D, while delaying wound
closure, does not slow the initial nerve regeneration after epithelial debridement or affect
VEGF levels.
Vitamin D treatment does not alter expression of cytokines after
wounding
Cytokines play an important role in integrating various aspects of the wound healing process.
Inflammatory mediators, at controlled levels, aid in advancing re-epithelization and serve as
communication bridges, relaying signals between immune cells, epithelial cells, and stromal
keratocytes. Vitamin D is able to modulate cytokine expression during inflammation in a num-
ber of tissues, including the cornea [38,39]. Therefore, cytokine expression was compared
between treatment groups after wounding. At both 12 and 24 hours post-wound, topical
1,25D3 did not change corneal mRNA expression of TNFα, IL-1β, TGFβ1, or TGFβ2 compared
to vehicle (Fig 7). 1,25D3 also did not influence TNFα protein expression at 12 hours, however
at 24 hours, there was a decrease in TNFα with 1,25D3 (S4 Fig).
Antimicrobial peptide expression is induced by vitamin D treatment 12
hours after wounding
Similar to cytokines, the antimicrobial peptide CRAMP has been shown to be important in the
cornea during inflammation [40]. The human homologue to CRAMP, LL-37, is important for
defense of the cornea against infection and increases migration of human corneal epithelial
cells [31]. At 12 hours after epithelial debridement, 1,25D3 treated corneas expressed an
increased level of CRAMP (3.58-fold) compared to both unwounded and vehicle treated ani-
mals (Fig 8). This increase could potentially offer protection to the exposed cornea while the
wound is re-epithelializing.
Vitamin D does not change the rate of wound closure in a human organ
culture model but does increase CYP27B1 expression
In addition to a mouse model of wounding, we also wanted to examine the effects of vitamin D
treatment in human corneal wound healing. Donor corneas were wounded by epithelial
Vitamin D and Corneal Wound Healing
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debridement and wound closure was followed over 24 hours. In this ex vivo model, vitamin D
treatment did not influence the rate of wound closure (Fig 9A and 9B). There was no statistical
difference in percent open wound at any time point between 1,25D3 and vehicle treatment.
There was however, a significant increase in CYP27B1 expression, a hydroxylase which
Fig 6. Topical vitamin D treatment does not change subbasal nerve density or VEGF expression following wounding. (A) Corneal whole mounts
were stained with anti-tubulin β III and subbasal nerves counted in a 10x10 morphometric grid to determine relative nerve densities. The graph represents the
average nerve density per field in vehicle or 1,25D3 treated corneas 18 hours after wounding. (n = 5 corneas/group). (B) VEGF expression was determined in
corneal homogenates 12 and 24 hours after wounding. For RNA analysis (left), relative expression was determined by RT-PCR analysis. Samples represent
10 pooled corneas per group at each time point. Graphs are representative data from one experiment (n = 3, 24hrs; n = 1, 12hrs) showing the mean ± SEM of
triplicate values. For protein analysis (right), total corneal protein was collected and ELISA performed. Data represent 8 pooled corneas per group at each
time point. Graphs are representative data from one experiment (n = 2, 24hrs; n = 1, 12hrs) showing the mean of duplicate values.
doi:10.1371/journal.pone.0152889.g006
Vitamin D and Corneal Wound Healing
PLOS ONE | DOI:10.1371/journal.pone.0152889 April 1, 2016 10 / 19
converts 25D3 to the biologically active 1,25D3, after 48 hours of wound healing in the human
corneas (1.65-fold increase; p<0.05) compared to pre-wounded epithelium. (Fig 9C).
Discussion
The cornea is the transparent anterior covering of the eye that refracts entering light for vision
and serves to protect the underlying ocular tissues from damage. After injury, it is essential to
have a well-coordinated corneal wound healing response to prevent loss of transparency and
hence vision and to maintain the protective barrier. Corneal wound healing is a complex
Fig 7. Cytokine expression at 12 and 24 hours after corneal wounding. TNFα, IL-1β, TGFβ1, and TGFβ2
expression was determined in corneal homogenates following 12 and 24 hours of wounding by RT-PCR.
Samples represent 10 pooled corneas per group at each time point. Graphs are representative data from one
experiment (n = 3, 24hrs; n = 1, 12hrs) showing the mean ± SEM of triplicate values.
doi:10.1371/journal.pone.0152889.g007
Fig 8. Vitamin D increases the expression of CRAMP in wounded corneas.CRAMP expression was
determined in corneal homogenates following 12 and 24 hours of wounding by RT PCR. 10 individual
corneas were isolated and pooled per time point per treatment group for each experiment. Graphs are
representative data from one experiment (n = 2, 24hrs; n = 1, 12hrs) showing the mean ± SEM of triplicate
technical repeats.
doi:10.1371/journal.pone.0152889.g008
Vitamin D and Corneal Wound Healing
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process that involves epithelial cell division and migration, death of stromal keratocytes, nerve
regeneration, and a localized inflammatory response resulting in infiltration of immune cells
and platelet extravasation from limbal vessels. All of these components are necessary for effi-
cient corneal wound healing. As vitamin D is well recognized to modulate inflammatory events
in many tissues, we sought to determine if vitamin D treatment influences the corneal wound
healing response. We observed that mice treated with topical vitamin D had a delay in sterile
wound closure, possibly the result of an acute increase in neutrophil infiltration.
Following debridement of a 2 mm diameter circular area, re-epithelialization of the murine
cornea takes approximately 24 hours, resulting in complete covering of the wounded area with
basal epithelial cells [11,41]. Re-epithelialization involves first the migration of epithelial cells
to cover the wound and then a proliferative phase to aid in re-stratification. Immediately after
wounding, cell division is inhibited in the wound area, to allow for efficient migration
[18,42,43]. Our data is in agreement with this model of corneal-wound healing, with almost no
basal epithelial cell proliferation in the central cornea, within the wounded area at 18 hours
post-wound, a time when the wound is still being re-epithelialized, in either vitamin D or vehi-
cle treated mice. There was also no significant difference in basal epithelial cell division in the
peripheral corneal regions between the treatment groups. However, as noted (Fig 3), a reduc-
tion in cell proliferation with vitamin D treatment might become apparent with an increased
sample size, as there appeared to be a slight decrease in proliferation with vitamin D. If
Fig 9. Topical vitamin D treatment does not affect wound closure rate in a human organ culture
woundingmodel but wounded corneas express a higher level of the vitamin D activating enzyme,
CYP27B1. (A, B) Corneal wounds were monitored by fluorescein staining every 6 hours for 24 hours. Data
were analyzed with repeated measures ANOVA and Bonferroni’s correction for multiple comparisons. (n = 5)
(C) Corneal epithelium was collected at the time of wounding (initial) and after 48 hours of regrowth (regrown)
and CYP27B1 expression was determined by RT-PCR. Data were analyzed by Student’s two-tailed t-test.
* = p<0.05 (n = 4).
doi:10.1371/journal.pone.0152889.g009
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confirmed, this could account for part of the delay in wound closure, seen with vitamin D
treatment.
There was a significant delay in wound closure at both 12 and 18 hours with topical vitamin
D treatment, and wounds still remained open at 24 hours, although not statistically signifi-
cantly more so than in controls. This delay could also potentially be a result of decreased epi-
thelial cell migration. Notably, a recent study demonstrated similar results when 1,25D3 was
applied to mouse corneas during an ex vivo alkali burn model, with delayed re-epithelialization
resulting from vitamin D treatment.[44] Interestingly, vitamin D receptor (VDR) knockout
mice also had delayed wound healing in a corneal abrasion model compared to wild type con-
trols.[45] In this study, normal wound healing rates were restored in the knockout animals
with a high-lactose, Ca2+, and PO4
− diet, indicating that vitamin D’s calcemic effects were
important for corneal wound healing. It would therefore be relevant to examine how vitamin D
influences calcium signaling events during re-epithelialization in further studies.
In the human organ culture model of wounding, vitamin D did not change the wound clo-
sure rate, despite the finding that in vitro, vitamin D treatment decreased human corneal epi-
thelial cell proliferation (S5 Fig). Importantly, however, this ex vivo model does not include
contributions from the ocular surface system, including the tear film, lacrimal glands, eyelids,
and conjunctival tissues, which all work together in vivo during ocular surface and corneal
damage. In particular, the human organ culture model does not account for the influence of
infiltrating inflammatory and immune cells, which are critical for effective wound healing.
Epithelial debridement results in an acute inflammatory response that is necessary for effi-
cient wound healing and re-epithelialization. Animal models of corneal injury have demon-
strated that wounding triggers the infiltration of immune cells into the cornea from the limbal
vessels. This infiltration is necessary for proper re-epithelialization, as defects in neutrophil
trafficking result in delayed wound closure [10–12,17]. In addition to a loss of neutrophil infil-
tration, excess accumulation also results in delayed re-epithelialization [13,18]. This demon-
strates that while a limited inflammatory infiltration is beneficial, too many neutrophils impair
corneal healing. We therefore examined neutrophil infiltration into the corneal stroma in our
model. With topical vitamin D treatment, in addition to delayed wound closure, there was an
increase in neutrophil accumulation throughout the cornea and specifically in the wounded
area at 18 hours. The increase in neutrophils seen with vitamin D could in part be a result of an
increase in chemotactic signals. CXCL1 (C-X-C motif ligand 1, GRO1, KC) a chemokine that
recruits neutrophils to sites of injury and inflammation [32,33] and has been shown to be ele-
vated following corneal abrasion [10]. There was a greater amount of CXCL1 protein in
wounded corneas with vitamin D treatment, just prior to the peak in neutrophils, potentially
contributing to the greater numbers of neutrophils in the corneas of these mice at this time.
There is an apparent discrepancy between the CXCL1 RNA and protein data; while protein
expression is higher with vitamin D treatment at 12 hours post-wound, CXCL1 gene expres-
sion is decreased at this time relative to vehicle control (Fig 5). Vitamin D could be upregulat-
ing CXCL1 mRNA rapidly (prior to 12 hours), resulting in an increase in CXCL1 protein
translation and secretion (evident at 12 hours), then decreases CXCL1 gene regulation with
time. It would therefore be important to examine earlier time points, immediately after wound-
ing, to determine vitamin D’s effect on early chemokine gene expression. It would also be inter-
esting to further explore the mechanism behind the decrease in CXCL1 protein at 24 hours
with vitamin D treatment and examine if this is a result of increased degradation, decreased
secretion, or a decrease in protein translation, and to examine this effect on neutrophil infiltra-
tion at later time points.
Previous studies have shown that an increase in neutrophil infiltration disrupts wound heal-
ing and re-epithelialization [13], however the exact mechanism of this remains uncertain, as
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does the amount of neutrophil infiltration that normally occurs in a human corneal epithelial
wound. Excess neutrophil accumulation in the wounded area could potentially block epithelial
cell migration into the area and therefore result in a delay in wound closure. However, the
increase in neutrophil infiltration with vitamin D would be beneficial in a non-sterile wound
environment, where neutrophils would be an important mediator of infection clearance. One
explanation for the increase in neutrophils with topical vitamin D, which was not examined in
this study, is disruption of neutrophil apoptosis. Neutrophils undergo rapid programmed cell
death, or apoptosis, following infiltration to the site of inflammation [46]. If this process is
inhibited, there would be a greater number of neutrophils remaining in the wounded area.
Another interesting situation to further explore would be the effect of vitamin D on other
inflammatory cells that are known to migrate into the wounded area. Local dendritic cells,
Langerhan’s cells, are needed for re-epithelization, migrating with epithelial cells towards the
wound center [19]. NK cells and γδ T lymphocytes also infiltrate into the cornea and influence
recovery. γδ T cell-deficient mice have delayed wound re-epithelialization and a decrease in
corneal neutrophils and limbal platelet accumulation [12]. Depleting NK cells in an epithelial
abrasion model increases neutrophil infiltration while negatively affecting re-epithelialization
and nerve regeneration. In this study, Liu et al. (2012) suggest that NK cells act to limit acute
inflammatory events. In vitro studies suggest that vitamin D has a negative effect on NK cell
development [47]. Therefore, investigation into vitamin D’s influence of NK cells in wounding
is warranted.
In order to further dissect the effect of vitamin D treatment on the wound healing process,
nerve regeneration and cytokine expression were also examined in the wounded corneas.
Nerves release trophic factors, which help to maintain the health of the corneal epithelium and
stroma. Various factors play a role in nerve regeneration, including VEGF, produced by the
wounded epithelium and infiltrating neutrophils [27]. However, there was no difference in
either nerve density in the wounded corneas or VEGF expression with topical vitamin D treat-
ment. Cytokines also play an integral role in the localized inflammatory reaction following
wounding [43,48,49]. Disruption in TGFβ signaling delays corneal re-epithelialization
[43,50,51]. IL-1 and TNFα also are important mediators of corneal injury induced inflamma-
tion, influencing both proliferation and migration of epithelial cells [48,49]. Mice deficient in
these cytokines have compromised corneal wound healing, with decreased dendritic cell migra-
tion in the wounded epithelium [19,52,53]. IL-1 is released from the injured epithelium and
also induces keratocyte cell death, a coordinated aspect of the wounding process [14,15]. Inter-
estingly, when NF-κβ signaling is disrupted, corneal wound healing is delayed, causing a
decrease in pro-inflammatory cytokines and a reduction in cell migration [54]. However, levels
of IL-1β, TNFα, TGFβ1, and TGFβ2 were not changed with vitamin D treatment in these
experiments.
While this study did not detect changes in VEGF/cytokines with vitamin D treatment, it is
important to note that whole corneas were used in the analysis. Therefore, the results reflect
general corneal expression, with contributions from epithelial, stromal, and immune cells. Sub-
tle differences, for example, in epithelial expression of cytokines or neutrophil expression of
VEGF, caused by vitamin D, might have been masked. This especially merits consideration,
given the increase in neutrophils with vitamin D treatment. It would therefore be interesting to
examine cytokine expression in the isolated epithelium and compare this to results from whole
corneal expression.
Another aspect of wound healing is the protection of injured cornea from infection during
re-epithelialization. Antimicrobial peptides (AMP) are small cationic peptides which have
been shown to be expressed during wound healing, providing a line of defense against patho-
gens [40,55–59]. One of these AMPs, cathelicidin (murine CRAMP/ human LL-37), was first
Vitamin D and Corneal Wound Healing
PLOS ONE | DOI:10.1371/journal.pone.0152889 April 1, 2016 14 / 19
identified in neutrophils, however, now it is known to be expressed in the corneal epithelium
[60]. In addition to its broad range killing ability, LL-37 is also able to modulate inflammatory
signals, bind LPS, and potentiate the wound healing process. It has also been shown to be che-
motactic for neutrophils and T lymphocytes [61] and increases the migration of human corneal
epithelial cells in culture [31]. Vitamin D augments the production of LL-37 in various human
tissues; however it is unclear if CRAMP, the murine orthologue, is influenced by vitamin D. In
our study, at 12 hours after the initial wound, vitamin D increased CRAMP RNA expression.
Therefore, while delaying early wound closure, vitamin D treatment could simultaneously be
enhancing protection of the exposed epithelium, preventing infection of the underlying tissue.
Both the increase in CRAMP and neutrophils with vitamin D could be of benefit in an infected
wound.
Vitamin D is known to modulate inflammation in a variety of tissues and is protective
against the development several ocular diseases [62]. The current study highlights the fact that
various factors influence the effects of vitamin D during inflammation and that its role in
inflammation is complex. The response to inflammation can change based on the cell types
involved, the source of immune stimulus, the tissue microenvironment, timing of vitamin D
administration, vitamin D concentration, and the relative expression of activating and inacti-
vating hydroxylases. The effect of topical vitamin D on corneal wound healing is an important
area of further research and should be considered when evaluating vitamin D as a therapeutic
option during inflammatory conditions.
Supporting Information
S1 Fig. Neutrophil counts.Morphometric counting frame with the accepted line in green and
forbidden line in red dashes. Neutrophil “donut-shaped” nuclei were counted using DAPI
(blue) and cross-checked with FITC-labeled Ly6G staining (green) throughout the z-stack in
each image. Scale bar = 20μm.
(TIF)
S2 Fig. Nerve relative density. The left panel shows the 10x10 grid used to count subbasal epi-
thelial nerves stained with NorthernLights™ NL557-conjugated anti-β-III tubulin (red). In this
image, 57 out of 100 boxes contain a subbasal nerve fiber. A large stromal nerve can be seen
beneath the plane of the thin subbasal nerves. On the right, basal epithelial cells are visible,
stained with DAPI (blue). Scale bar = 20μm.
(TIF)
S3 Fig. Vitamin D increases the percentage of open wound at 18 hours after epithelial
debridement. An initial wounding experiment was performed to test the effect of a range of
vitamin D concentrations (10−7 to 10-9M) on corneal wound closure. Mice were imaged imme-
diately after corneal wounding and at 18 hours post-wound with fluorescein staining to visual-
ize wound area. Mice received topical vehicle (0.02% ethanol/PBS) or 1,253 (10
−7, 10−8, or 10-
9M) twice at the time of wounding and every 6 hours through 18 hours. Wound area remaining
open was determined as a percentage of original wound area. Data represent mean ± SEM and
were analyzed with one-way ANOVA and Bonferroni’s correction for multiple comparisons,
p<0.05 (n = 3 mice/group).
(TIF)
S4 Fig. Vitamin D treatment decreases TNFα protein expression at 24 hours after corneal
debridement. To determine vitamin D’s effect on pro-inflammatory cytokine expression fol-
lowing epithelial wounding, TNFα protein levels were determined in corneal homogenates 12
and 24 hours after wounding by ELISA. At 12 hours post-wounding, there was no change in
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TNFα protein with treatment. However, at 24 hours, vitamin D treatment decreased protein
expression in corneal homogenates compared to vehicle (700pg/mg compared to 391pg/mg).
Data represent 8 pooled corneas per group at each time point. Graphs are representative data
from one experiment (n = 2, 24hrs; n = 1, 12hrs) showing the mean of duplicate values.
(TIF)
S5 Fig. Cell viability following vitamin D treatment.Human corneal epithelial cells (hTCEpi
[63]) were plated in 96 well plates and treated with 1,25D3 (10
-7M). Following 24 hours incuba-
tion, 0.5mg/ml MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) was
added to each well and cells were incubated for an additional 2 hours at 37°C. Colorimetric
changes were measured at wavelength 590 on a spectrophotometer and OD values normalized
to untreated control cells. 0.02% benzalkonium chloride in PBS (BAC) was used as a positive
control, indicating loss of cell viability. Data represent mean +/- SEM of 4 independent experi-
ments. Statistical analysis was by Student’s t-test with  p = 0.022.
(TIF)
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